The Role of PD-1/PD-L1 Axis in Treg Development and Function: Implications for Cancer Immunotherapy

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s221340
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

ARID1A Alterations Function as a Biomarker for Longer Progression-Free Survival After Anti-Pd-1/Pd-L1 Immunotherapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2020English

PD-1/PD-L1: A Novel Target for Immunotherapy in Patients With Advanced and Metastatic Non-Small Cell Lung Cancer

Medicinski podmladak
2018English

The Role of PD-1/PD-L1 Signaling Pathway in Antitumor Immune Response

Klinicka Onkologie
Oncology
2016English

FcγRs Modulate the Anti-Tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis

Cancer Cell
Cancer ResearchOncologyCell Biology
2015English

Intratumoral Immune Cells Expressing PD-1/PD-L1 and Their Prognostic Implications in Cancer: A Meta-Analysis

International Journal of Biological Markers
OncologyCancer ResearchClinical BiochemistryForensic MedicineMedicinePathology
2018English

CD84 Regulates PD-1/PD-L1 Expression and Function in Chronic Lymphocytic Leukemia

Journal of Clinical Investigation
Medicine
2018English

Prognostic Significance of Pd-L1 and Phosphorylated Erk Expression in T-Cell Lymphoma: Pd-1/Pd-L1 Axis Activates Intracellular Erk Signaling in Tumor Cells

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

Breast Care
SurgeryOncology
2016English

PD-1/PD-L1 Blockade: A New Promising Therapy for the Treatment of Pancreatic Cancer?

Pancreas - Open Journal
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy